My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    Breast-feeding modifies the association of PPARgamma2 polymorphism Pro12Ala with growth in early life: the Generation R Study.

    Mook-Kanamori DO, Steegers EA, Uitterlinden AG, Moll HA, van Duijn CM, Hofman A, Jaddoe VW.

    Diabetes. 2009 Apr;58(4):992-8. Epub 2009 Feb 2.PMID: 19188432 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fetal and maternal peroxisome proliferator-activated receptor gamma2 Pro12Ala does not influence birth weight.

    Pfab T, Poralla C, Richter CM, Godes M, Slowinski T, Priem F, Halle H, Hocher B.

    Obesity (Silver Spring). 2006 Nov;14(11):1880-5.PMID: 17135601 [PubMed - indexed for MEDLINE]Related articles

    3.

    Association of pro12Ala polymorphism in the peroxisome proliferative-activated receptor gamma2 gene with obesity and hypertension in Korean women.

    Kim K, Lee S, Valentine RJ.

    J Nutr Sci Vitaminol (Tokyo). 2007 Jun;53(3):239-46.PMID: 17874829 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.

    Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W.

    J Hypertens. 2005 Feb;23(2):301-8.PMID: 15662218 [PubMed - indexed for MEDLINE]Related articles

    5.

    The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.

    Pihlajamäki J, Vanhala M, Vanhala P, Laakso M.

    Obes Res. 2004 Feb;12(2):187-90.PMID: 14981210 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.

    Kang ES, Park SY, Kim HJ, Kim CS, Ahn CW, Cha BS, Lim SK, Nam CM, Lee HC.

    Clin Pharmacol Ther. 2005 Aug;78(2):202-8.PMID: 16084854 [PubMed - indexed for MEDLINE]Related articles

    7.

    Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.

    Lindi VI, Uusitupa MI, Lindström J, Louheranta A, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Tuomilehto J; Finnish Diabetes Prevention Study.

    Diabetes. 2002 Aug;51(8):2581-6.PMID: 12145174 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

    Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E; Berlin Diabetes Mellitus (BeDiaM) Study.

    Diabetes. 2002 Aug;51(8):2653-7.PMID: 12145184 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients.

    Vaccaro O, Lapice E, Monticelli A, Giacchetti M, Castaldo I, Galasso R, Pinelli M, Donnarumma G, Rivellese AA, Cocozza S, Riccardi G.

    Diabetes Care. 2007 May;30(5):1156-61. Epub 2007 Jan 26.PMID: 17259473 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes.

    Vogel U, Christensen J, Nexø BA, Wallin H, Friis S, Tjønneland A.

    Carcinogenesis. 2007 Feb;28(2):427-34. Epub 2006 Sep 6. Erratum in: Carcinogenesis. 2007 Sep;28(9):2062. PMID: 16959787 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.

    Honka MJ, Vänttinen M, Iozzo P, Virtanen KA, Lautamäki R, Hällsten K, Borra RJ, Takala T, Viljanen AP, Kemppainen J, Pihlajamäki J, Knuuti J, Nuutila P, Laakso M.

    Metabolism. 2009 Apr;58(4):541-6.PMID: 19303976 [PubMed - indexed for MEDLINE]Related articles

    12.

    Type 2 diabetes gene TCF7L2 polymorphism is not associated with fetal and postnatal growth in two birth cohort studies.

    Mook-Kanamori DO, de Kort SW, van Duijn CM, Uitterlinden AG, Hofman A, Moll HA, Steegers EA, Hokken-Koelega AC, Jaddoe VW.

    BMC Med Genet. 2009 Jul 17;10:67.PMID: 19615048 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women.

    Rhee EJ, Oh KW, Yun EJ, Jung CH, Park CY, Lee WY, Oh ES, Baek KH, Kang MI, Park SW, Kim SW.

    Exp Mol Med. 2007 Dec 31;39(6):696-704.PMID: 18160840 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    [Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes]

    Dong CP, He L, Li JN, Ye F, He M, Wang Y.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Aug;25(4):447-51. Chinese. PMID: 18683148 [PubMed - indexed for MEDLINE]Related articles

    15.

    The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.

    Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

    Diabetologia. 2007 Dec;50(12):2451-60. Epub 2007 Sep 27.PMID: 17898990 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Common polymorphisms in the PPARgamma2 and IRS-1 genes and their interaction influence serum adiponectin concentration in young Finnish men.

    Mousavinasab F, Tähtinen T, Jokelainen J, Koskela P, Vanhala M, Oikarinen J, Keinänen-Kiukaanniemi S, Laakso M.

    Mol Genet Metab. 2005 Apr;84(4):344-8. Epub 2005 Jan 25.PMID: 15781195 [PubMed - indexed for MEDLINE]Related articles

    17.

    Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.

    Niskanen L, Lindi V, Erkkilä A, Sivenius K, Luoma J, Ylä-Herttuala S, Laakso M, Uusitupa MI.

    Metabolism. 2003 Feb;52(2):213-7.PMID: 12601635 [PubMed - indexed for MEDLINE]Related articles

    18.

    The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.

    Zouari Bouassida K, Chouchane L, Jellouli K, Chérif S, Haddad S, Gabbouj S, Danguir J.

    Diabetes Metab. 2005 Apr;31(2):119-23.PMID: 15959417 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.

    Malecki MT, Frey J, Klupa T, Skupien J, Walus M, Mlynarski W, Sieradzki J.

    Diabetes Res Clin Pract. 2003 Nov;62(2):105-11.PMID: 14581147 [PubMed - indexed for MEDLINE]Related articles

    20.

    The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.

    Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, Dennis L, Fielding BA, Karpe F.

    Diabetologia. 2006 Jan;49(1):158-68. Epub 2005 Dec 17.PMID: 16362285 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity